United Conference of B2B

Theme : Novel trends and approaches in Pharmaceutical Industry

Webinar on B2B | July 14-15, 2021

About The Conference

On behalf of United Conferences, we are overwhelmed to welcome all the interested participants to attend “United Conference of Pharma B2B” Webinar on July 14-15, 2021. This conference boats of a huge variety of Keynote presentations, plenary talks, Poster presentations and Career development programs.

United Conference on Pharma B2B aims to bring together a significant number of leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Research and Development on Pharmaceutical Industry It is a foremost integrative platform for researchers, educators and practitioners alike to present and explore the latest innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in Pharma Industry.

Previous Keynotes

Hashim Ahmed

WHO Fellow, Sr. Director-Head Of Formulation And Manufacturing, Avomeen, United States

Director, Global Analytical Science & Technology - Pharma & Forensics Bristol Myers Squibb, United States

Timur Güvercinci

Director, Head of External Supply Quality Processes and Development bei Merck Gruppe Global Quality, Germany

Stephan O. Krause

Head of Product Quality Group at AstraZeneca Biologics, USA

CEO PharSafer Associates Ltd - Global Leaders in Drug Safety, United Kingdom

Asif Mahmood

Chief Safety Officer/Vice President Global Safety & Pharmacovigilance, Medicago, Canada

Sunil Verma

DIRECTOR – PHARMACOVIGLANCE, HAROM Solutions, India

Abdalla Abotaleb - (WHO)

Project Manager, World Health Organization, Spain

Mathew Cherian

Director & Senior Fellow Pharmaceutical Development, Hospira, a Pfizer Company, United States

Eluemuno R Blyden

Founder/CEO at Avril Biopharma, inc., United States

Damon Smith
Damon Smith

CEO TALLC Corporation Inc., Mirabel, Quebec, Canada

Ali Moghaddam
Ali Moghaddam

Vice President & General Manager, Toronto, Ontario, Canada

Jim Hauske

President and founder at Sensor Pharma, United States

Faculty member at Roswell Park Comprehensive Cancer Center, Roswell Park Cancer Institute, USA

James T. O'Donnell

Pharmacologist Drug Expert, Associate Professor at Rush Medical College, United States

Ongoing Keynotes

Mark Nuijten
Mark Nuijten

A2M, member of the MINERVA Health Economics Network, Ltd

brahim Ghareeb Madian Mohammed

GMP executive Consultant

Speakers

Dhaval Surti

Heading QA, Emcure Pharmaceuticals Limited, India

Md. Saddam Nawaz

Head of Quality Assurance, ACI HealthCare Limited, Bangladesh

Elie Arslan

Manager, Technical QA and Document Control at Ajinomoto Bio-Pharma, United States

Majdi Ayoub

Quality & Validation Manager at Rieckermann GmbH Jordan

Dishant Sanghavi

Senior Manager - Global Quality and Compliance, Sun Pharma, India

Mohammad Refaat Khattab, Ph.D

Scientist at Texas A&M University - USA

Virtual Exhibitors

ASTE Logo

ASTE Pharmaceuticals, Medical & Laboratory Supplies

TGMP Consulting

Webinar Registration Charges

  • Keynote/ Speaker Registration 199 USD
  • Speaker Registration 149 USD
  • Delegate Registration 99 USD
  • Student Delegate Registration 50 USD
  • Poster Presentation Registration 50 USD
  • Video Presentation Registration 50 USD
  • E-Banner Registration 50 USD

Who Can Attend

  • Pharma IT & Data
  • Big Data
  • FAIR Data
  • Data Management
  • Data Analytics
  • R&D IT
  • Real-World Data & Evidence
  • AI in Drug Development
  • Machine Learning
  • AI Tools
  • SmartLabs
  • Lab Informatics
  • Automation
  • Robotics
  • Hospitals, healthcare system & healthcare providers
  • Health insurance companies
  • Biotech companies
  • Healthcare-related associations and foundations
  • Molecular Design
  • Modelling Platforms
  • Research IT
  • Chemoinformatics
  • Bioinformatics
  • Machine Learning Tools
  • Custom AI Solutions
  • Research Institutes and members
  • AI Softwares & Platforms
  • Discovery Workflow
  • Lab Compliance
  • Computerized Systems
  • Managers, Directors, and VPs
  • Pharmaceutical companies
  • Medical device manufacturers
  • Industry influencers (solutions providers, educational organizations, government entities and venture capitalists)

Why Choose Us

  • Global & Local Expertise
  • Prospective Attendees
  • Larger worldview of the profession
  • We’re passionate about what we do
  • We focus on your career growth
  • Transparency in Communication
  • Open gateway towards INNOVATION
  • Strong sense of identification
  • Quality without compromise
  • Highly organised and structured scientific programs

Key Takeaways

  • Professional Worldwide
  • International Recognition of Researchers
  • Knowledge into Asset
  • Cognizance of leading Cutting – Edge technologies
  • Publication of Abstracts in preeminent supported journals
  • New Accomplishments with Edu – tech ideas
  • Exposure to the upcoming business trends
  • Free access to our forthcoming International events
  • Certificate of presentation with International signatories

United Pharma Technologies Collaborations and Associations

Penelope Przekop
Chief Compliance Officer at Engrail Therapeutics | CEO at PDC Pharma Strategy
Biography: Penelope Przekop, MSQA, RQAP-GCP is the CEO of PDC Pharma Strategy, a consulting firm that focuses on strategic GxP regulatory and corporate compliance. She currently dedicates half of her time to serving as Chief Compliance Officer for Engrail Therapeutics, Inc. She has 30-plus years of broad and deep pharma industry experience and is known for her creative approaches to developing efficient quality management strategies that enable companies of all sizes to build upon their unique drug development history and strengths while ensuring compliance.
Penelope earned her B.S. in Biology from Louisiana State University and her M.S in Quality Systems Engineering from the Kennesaw State University. She is a frequent industry speaker and writer. She is the author of Six Sigma for Business Excellence (McGraw-Hill). Her upcoming book, 5-Star Career (Productivity Press, fall 2021), will relay how readers can apply the proven science of quality management to career development.
Stephan O. Krause
Stephan O. Krause
Head of Product Quality Group at AstraZeneca Biologics, USA
Biography: Stephan Krause, PhD, is currently Quality Director and PQL Team Leader in Development Quality, AstraZeneca Biologics. He is a results-driven leader with 20 years of technical, managerial, and executive experiences for quality and technical functions within global operations. He is a frequent conference presenter and author and has won multiple industry awards for his publications and leadership in improving industry best practices. Stephan was invited by FDA several times to present an industry perspective to the agency on relevant current topics. He is a member of PDA’s Board of Directors and is co-chair of AMTP Advisory Board and a member of the Advisory Board for Biopharmaceuticals and Regulatory Affairs/Quality.
Biography: Graeme Ladds has worked in Global Pharmacovigilance and Medical Affairs for the last 30 years working with many top ten Pharma in senior positions. He has worked in all areas of Pharmacovigilance and has designed and improved many IT solutions to aid both Medical Affairs and Pharmacovigilance. Graeme is also an experienced GCP/PV auditor having audited many Companies globally as well as helping Companies in Regulatory Inspections. He now works in his CRO - PharSafer Associates Ltd
Liana Kasyan
Founder/CEO and Principal PV Consultant at ETL Pharmacovigilance Center Ltd. Armenia
Biography: Founder/CEO and Principal PV Consultant at the ETL Pharmacovigilance Center Ltd., - Pharmacovigilance Instructor at the Open Education Office of the American University of Armenia, - Member of International Society of Pharmacovigilance (ISoP), - International Editorial Board Member for the Journal of Pharmacovigilance and Drug Research (JPADR), - Reviewer of Master Тheses at the Faculty of Public Health of Yerevan State Medical University, - Board Member of Armenian Association of Specialists in Evidence-Based Medicine (AASEBM), - Co-founder of “Do not Harm’’ Health NGO.
Biography: Fengzhi Li became a faculty member at Roswell Park Comprehensive Cancer Center (legal name: Roswell Park Cancer Institute, the first cancer institution in the US history and is a US NCI-designated comprehensive cancer center) in 2001 after finishing his postdoctoral training in Dr. Dario C. Altieri’s laboratory at Boyer Center for Molecular Medicine, Yale Medical School where he focused his research on the characterization of the function and expression regulation of a newly discovered antiapoptotic protein named survivin (a novel member of the inhibitor of apoptosis protein family). In 2006 he has been promoted to Associate Professor of Oncology at Roswell Park. As a chief scientist, he leads his lab using the survivin gene as a target and biomarker for targeted drug discovery. He has transitioned his Roswell Park cancer research lab from basic to translational cancer research over the past decade. His current research interests focus on targeted anticancer drug discovery, development and mechanism of action (MOA) studies. His research has been supported through federal agencies (NIH/NCI, DOD) as well as other public/private foundations and partnerships. He has published over 80 publications (h-index, 47 and i10-index, 73) with a total citation of over 13,000 times. He is the editorial board members in several academic journals including J Exp Clin Can Res (2019 IF: 7.068), Am J Transl Res (2019 IF: 3.375) and Int J Mol Sci (2019 IF: 4.556). He is also the Chief Scientific Officer (CSO) of Canget BioTekpharma LLC (www.canget-biotek.com) and helps Canget to develop innovative targeted anticancer drugs (high efficacy with low toxicity) for benefiting cancer patients.
brahim Ghareeb Madian Mohammed
Ibrahim Ghareeb Madian Mohammed
GMP executive Consultant
Biography: Quality-oriented pharmaceutical professional with 12 years’ experience in Quality assurance environment. Having sound experience in quality system improvement and in-depth knowledge in diverse GMP guidelines qualified me to be part of a global consultancy entity as GMP executive Consultant"

Submit Manuscript

Manuscript Details

Author Details